Interaction of transforming growth factor‐β‐Smads/microRNA‐362‐3p/CD82 mediated by M2 macrophages promotes the process of epithelial‐mesenchymal transition in hepatocellular carcinoma cells

Citations Over TimeTop 11% of 2019 papers

Abstract

Abnormal tumor microenvironment and the epithelial-mesenchymal transition (EMT) are important features of tumor metastasis. However, it remains unknown how signals can form complicated networks to regulate the sustainability of the EMT process. The aim of our study is to explore the possible interaction between tumor-associated macrophages and tumor cells in the EMT process mediated by microRNA (miR)-362-3p. In this study, we found that by releasing TGF-β, M2 macrophages mediate binding of Smad2/3 to miR-362-3p promoter, leading to overexpression of miR-362-3p. MicroRNA-362-3p maintains EMT by regulating CD82, one of the most important members of the family of tetraspanins. Our finding suggests that miR-362-3p can serve as a core factor mediating cross-talk between the TGF-β pathway in tumor-associated macrophages and tetraspanins in tumor cells, and thus facilitates the EMT process.

Related Papers

• → miR‐96 regulates migration and invasion of bladder cancer through epithelial‐mesenchymal transition in response to transforming growth factor‐β1(2018)31 cited
• → Human Bronchial Epithelial Cells Are Resistant to Transforming Growth Factor (TGF)-β1-Induced Epithelial-Mesenchymal Transition (EMT).(2009)
• The Progress in Researches on TGF-β and its Receptor in Marfan Syndrome(2008)
• TGF-β induced epithelial-mesenchymal transition and the related therapeutic strategy(2009)
• → Study and prospects of transforming growth factor-β induced epithelial-mesenchymal transition on pulmonary fibrosis(2012)